Back

Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late-breaking trials 1 Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Lucas Boersma

St Antonius Hospital, Nieuwegein (Netherlands (The))

10 More presentations in this session

Presentation thumbnail
A randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation:The CIRCA-DOSE Study
Doctor J. Andrade (Vancouver, CA)
Slides Video
Presentation thumbnail
CIRCA-DOSE Study - Discussion
Professor D. Scherr (Graz, AT)
Slides Video
Presentation thumbnail
Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - AVATAR AF
Professor P. Kanagaratnam (London, GB)
Slides Video
Presentation thumbnail
Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - Discussion
Professor J. Merino (Madrid, ES)
Slides Video
Presentation thumbnail
GOLD AF registry - Discussion
Slides Video

Access the full session

Session thumbnail
Late-breaking trials 1

The Event

Event poster

EHRA 2019

17 March - 19 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources